Star Combo Pharma Ltd (S66) — Cash Flow-to-Debt Ratio
Star Combo Pharma Ltd (S66) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of AU$575.23K could theoretically repay 0% of its total liabilities (AU$8.30 Million) in one year. See financial flexibility index of Star Combo Pharma Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Star Combo Pharma Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Star Combo Pharma Ltd across 10 annual periods. For the full cash flow conversion analysis, see S66 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Star Combo Pharma Ltd (2016–2025)
Year-by-year debt coverage analysis for Star Combo Pharma Ltd. Check S66 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | AU$11.94 Million | AU$10.19 Million | ▲ +3546.3% |
| 2024 | -0.03x | AU$-316.45K | AU$9.30 Million | ▼ -116.3% |
| 2023 | 0.21x | AU$1.88 Million | AU$8.97 Million | ▲ +1831.2% |
| 2022 | 0.01x | AU$87.11K | AU$8.04 Million | ▼ -76.7% |
| 2021 | 0.05x | AU$331.53K | AU$7.13 Million | ▲ +146.7% |
| 2020 | -0.10x | AU$-1.02 Million | AU$10.22 Million | ▲ +65.8% |
| 2019 | -0.29x | AU$-2.19 Million | AU$7.51 Million | ▲ +56.0% |
| 2018 | -0.66x | AU$-1.84 Million | AU$2.78 Million | ▼ -358.1% |
| 2017 | 0.26x | AU$932.20K | AU$3.64 Million | ▼ -36.6% |
| 2016 | 0.40x | AU$1.30 Million | AU$3.21 Million | — |